Role of Cocaine in Neuro-AIDS by HIV 1B and C Clades
Role of Cocaine in Neuro-AIDS by HIV 1B and C Clades
批准号:
7685336
负责人:
MADHAVAN P. NAIR
金额:
$33.78万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2013-08-31
关键词:
AIDS Dementia ComplexAbbreviationsAcquired Immunodeficiency SyndromeAffectAfrica South of the SaharaAgeAmericanAnti-Inflammatory AgentsAnti-inflammatoryAntiviral AgentsAsiaAstrocytesAttenuatedBiological ModelsBrainCCL2 geneCellsClassificationClinicalCocaineCocaine AbuseCocaine UsersCognitiveComplementContractsCountryCrack CocaineCrimeDementiaDendritic CellsDevelopmentDioxygenasesDisease ProgressionDrug abuseDrug usageEnzymesEpidemicEuropeExperimental ModelsFamilyFigs - dietaryFutureGene ExpressionGenetic VariationHIVHIV InfectionsHIV-1HouseholdHumanImmuneImmune responseIn VitroIndiaInfectionInflammatoryInositolInstitutesIntegration Host FactorsInterleukin-6InvestigationMAPK14 geneMacrophage Inflammatory ProteinsMediatingMicrogliaMilitary PersonnelMinorMitogen-Activated Protein KinasesMitogensNeuraxisNeurologicNeuronsNeuropathogenesisNeurotoxinsNomadsOrganPathogenesisPatientsPersonsPharmaceutical PreparationsPhosphotransferasesPopulationPreventiveProductionPropertyProtein KinaseProteinsQuinolinic AcidRANTESRecombinantsReportingRiskRisk FactorsRoleSignal TransductionSignal Transduction PathwaySmall Interfering RNASurveysT-Cell ActivationTherapeuticTimeUnited StatesVaccinesViralVirusVirus DiseasesWestern Worldchemokinecocaine usecytokinedesigndrug of abuseepidemiologic datafrontal lobegp-120 Antigenindolamineinhibitor/antagonistmacrophagemembermethyl tryptophanmitogen-activated protein kinase p38monocytemotor disorderneurotoxicnovelnovel strategiespandemic diseasepreventpublic health relevancestress activated protein kinasestress-activated protein kinase 1therapeutic target
中文摘要
描述(由申请人提供):在美国和西方世界发现的主要HIV-1亚型是进化枝B,与撒哈拉以南非洲和亚洲存在的进化枝C显著不同。据估计,在大约4600万感染HIV-1的人中,超过56%的感染仅与C分支有关,并且HIV-1C感染正在迅速蔓延到世界其他地区。艾滋病常伴有神经病理异常。可卡因是美国最广泛滥用的药物之一。目前对HIV-1神经发病机制或可卡因作用的理解来自美国和西方国家的B进化枝,没有关于可卡因对C进化枝神经发病机制的相互作用的信息。我们推测进化枝B和C对CNS细胞产生不同的作用,导致不同的神经发病机制,可卡因加剧了这些作用,其机制可能是由丝裂原活化蛋白(MAP)激酶信号转导通路的失调介导的。因此,我们将首次研究(目的#1a)在存在或不存在可卡因的情况下用进化枝B和C病毒体外感染对促炎细胞因子的产生和基因表达的影响,(TNF 1和IL-6),趋化因子(MCP-1和RANTES)和神经毒素(IDO)通过原代单核细胞和CNS细胞(星形胶质细胞、神经元、小胶质细胞),以及是否:(目的#1b)差异失调的机制是由丝裂原活化蛋白(MAP)激酶信号转导途径的调节介导的。此外,这些体外感染研究将与离体研究(目标2)进行比较、关联和补充,离体研究使用来自迈阿密正在研究的使用和不使用可卡因的初次HIV-1B感染受试者的单核细胞,以及在印度合作研究所正在研究的使用和不使用可卡因的HIV-1C感染受试者的单核细胞。来自这些研究的结果可以a)帮助开发治疗上有用的药物或试剂,其可以减弱或预防与进化枝特异性HIV-1感染和可卡因使用相关的神经发病机制,和B)设计新的策略以开发预防性和治疗性全球疫苗,其可以诱导针对多进化枝或重组大流行性HIV-1的跨进化枝抗病毒免疫应答。1感染,目前面临的世界,包括美国,其中非B亚型最近已报告在移民人口和我们的军事人员。公共卫生相关性本申请与PA-07- 307的目的具有重要相关性。本项目将首次通过体外和离体模型系统研究可卡因对HIV-1B和HIV-C感染中神经致病性分子的产生和基因表达的相互作用。确定进化枝特异性神经发病机制将有助于设计新的策略,以开发预防性和治疗性的全球疫苗,在使用药物和不使用HIV感染的受试者中,可以诱导针对包括美国在内的世界目前面临的多进化枝或重组大流行HIV-1感染的跨进化枝抗病毒免疫应答。
英文摘要
DESCRIPTION (provided by applicant): The predominant HIV-1 subtype found in US and Western World is clade B, which differs significantly from clade C that exists in sub-Saharan Africa and Asia. Estimates suggest that out of about 46 million people infected with HIV-1, more than 56 % of the infection is with clade C alone and HIV-1C infection is rapidly spreading to other parts of the world. AIDS is often accompanied by neuropathological abnormalities. Cocaine is one of the most widely abused drugs in the U.S. Current understandings of HIV-1 neuropathogenesis or the role of cocaine emanate from B clade from U.S. and Western countries and no information is available on the interactive role of cocaine on neuropathogenesis of C clade. We hypothesize that clade B and C exert differential effects on CNS cells leading to differential neuropathogenesis and cocaine exacerbates these effects and the mechanisms may be mediated by dysregulation of mitogen activated protein (MAP) kinases signal transduction pathways. Accordingly we will study (Aim #1a) for the first time the effects of in vitro infection with clade B and C virus in presence or absence of cocaine on production and gene expression of pro-inflammatory cytokines, (TNF1 &IL-6), chemokines (MCP-1& RANTES), and neurotoxin (IDO) by primary monocytes and CNS cells (astrocytes, neurons, microglial cells), and whether :(Aim #1b) the mechanism of differential dysregulation is mediated by modulation of mitogen activated protein (MAP) kinases signal transduction pathways. Further these in vitro infection studies will be compared, correlated and complemented with ex vivo studies (Aim #2) using monocytes from naive HIV-1B infected subjects who are using and non using cocaine being studied in Miami and cocaine using and non using HIV-1C infected subjects being studied at the collaborating institute in India. The results emanating from these studies may a) help to develop therapeutically useful drugs or agents which could attenuate or prevent the neuropathogenesis associated with clade specific HIV-1 infection and cocaine use and b) design novel strategies to develop preventive and therapeutic global vaccines that can induce cross-clade antiviral immune response against multiclade or recombinant pandemic HIV-1 infection that is currently facing the world including United States where non B subtypes have been recently reported in migrant populations and among our military personals. PUBLIC HEALTH RELEVANCE This application has significant relevance to the purpose of the PA-07-307.This project will study for the first time the interactive role of cocaine on production and gene expression of neuropathogenic molecules in HIV-1B and HIV-C infection by both in vitro and ex vivo model system. Identification of the mechanism of clade specific neuropathogenesis will help to design novel strategies to develop preventive and therapeutic global vaccines in drug using and non-using HIV infected subjects that can induce cross-clade antiviral immune response against multiclade or recombinant pandemic HIV-1 infection that is currently facing the world including United States.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nano-delivery of methanandamide across BBB to block cannabinoid induced effects in HIV-1 infection
-
批准号:9926429
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2015
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Nano-delivery of methanandamide across BBB to block cannabinoid induced effects in HIV-1 infection
-
批准号:8993465
-
项目类别:
-
资助金额:$52.01万
-
财政年份:2015
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Multifunctional Nanocarrier to Eradicate HIV from latently infected CNS cells and
-
批准号:9247861
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2014
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Multifunctional Nanocarrier to Eradicate HIV from latently infected CNS cells and
-
批准号:8736460
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2014
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Cocaine in the Neuropathogenesis of HIV infection: Role of HDAC2
-
批准号:8410634
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2013
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Novel Magneto-Electric Nanodelivery of Drugs to Eradicate HIV from CNS
-
批准号:8655176
-
项目类别:
-
资助金额:$20.63万
-
财政年份:2013
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Cocaine in the Neuropathogenesis of HIV infection: Role of HDAC2
-
批准号:8623124
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2013
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Novel Magneto-Electric Nanodelivery of Drugs to Eradicate HIV from CNS
-
批准号:8544686
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2013
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Mechanisms of Neuro-AIDS by HIV 1B and C Clades
-
批准号:8432831
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2010
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Mechanisms of Neuro-AIDS by HIV 1B and C Clades
-
批准号:8245854
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2010
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Mechanisms of Neuro-AIDS by HIV 1B and C Clades
-
批准号:8015185
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2010
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Mechanisms of Neuro-AIDS by HIV 1B and C Clades
-
批准号:8625335
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2010
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Mechanisms of Neuro-AIDS by HIV 1B and C Clades
-
批准号:8105437
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2010
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
-
批准号:7701126
-
项目类别:
-
资助金额:$54.96万
-
财政年份:2009
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
-
批准号:8468152
-
项目类别:
-
资助金额:$67.75万
-
财政年份:2009
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
-
批准号:8470272
-
项目类别:
-
资助金额:$8.99万
-
财政年份:2009
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
-
批准号:8071080
-
项目类别:
-
资助金额:$64.2万
-
财政年份:2009
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
-
批准号:8262396
-
项目类别:
-
资助金额:$62.28万
-
财政年份:2009
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
-
批准号:7901130
-
项目类别:
-
资助金额:$55.45万
-
财政年份:2009
-
负责人:MADHAVAN P. NAIR
-
依托单位:
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
-
批准号:8848224
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2009
-
负责人:MADHAVAN P. NAIR
-
依托单位:
海外基金